SlideShare a Scribd company logo
Testing Strategies for HIV and HCV:
similarities and differences
Dr Chloe Orkin
Consultant Physician & Honorary Reader in HIV Medicine
Barts Health NHS Trust
Deaths attributable to HIV and Hepatitis in Western Europe
Global Burden of Disease Study: Cowie et al J Hep 2014 ;60 (Suppl 1):O86
-A relatively higher burden of HIV-related mortality until 1995
-HIV mortality declines from 2000 onwards
-HCV deaths increasing
HIV care cascade - WHO target
WHO consolidated guidelines on HIV testing services. July 2015.
HIV care cascade - UK
Public Health England. HIV in the United Kingdom 2014 report. November 2014.
76%
HCV care cascade in the UK
1. Public Health England. Hepatitis C in the UK 2015 report. July 2015.
2. Harris RJ et al. J Hepatol 2014;61:530–7.
SVR
~50% 3% 63%
214,000 with HCV1
~100,000 diagnosed 6000 per year2
‘The great unknown’
svr
HIV/HCV cascades: failing to diagnose 90%
…. screening is the first step…
TESTING
SCREENING
ASSESSMENT
TREATMENT
CURE
HIV - where does testing happen in the UK ?
UK HIV testing summary
• HIV seroprevalence data underpins testing strategies
• HIV testing occurring (hospital/community)
• Tailor testing methods to the setting: oral swabs /rapid tests in
outreach/STI vs. serology in ante-natal or the ED
• De-exceptionalising HIV testing is important in non-traditional settings
• Staff perceptions affect successful implementation
• Sustainability is a key challenge in non-traditional settings such as the
ED/MAU/ITU
• HIV testing has moved beyond non-traditional settings into ‘DIY’ testing
UK Guidelines HCV Testing = targeted testing
At-risk populations:
• PWID (about 90% being
tested 1)
• Prisons (8% of receptions
tested within 30 days1)
• Immigration centres
• ‘Promote’ in GUM to those
at high risk
1. Cosgrove P. Public health England Report: Hepatitis Epidemiology in the South East
HCV Epidemic UK : gender
UK Epidemic: Ethnicity
Proportion testing positive for HCV-Ab by ethnicity in sentinel laboratories
in the South East , 2010-2014
Generalised epidemic= universal screening
• Targeted testing not helpful
• Universal approach
US HCV: screening amongst ‘baby-boomers’
• Prevalence in this
cohort > 3%
• One time ‘birth cohort’
screening if born 1945–65
• Highly cost-effective
Centers for Disease Control and Prevention. MMWR 2012;61:1–33.
Centers for Disease Control and Prevention. MMWR 1998;47:1–39.
Smith BD et al. AASLD 2011. Abstract 394.
Differences in testing in the UK
HCV HIV
Are we missing HCV cases?
Sero-prevalence surveys are helpful

More Related Content

PPTX
HCV Treatment Access across Europe - Raquel Peck
ReShape
 
PPTX
Hepatitis C Research Gaps - Graham Cooke
ReShape
 
PDF
Facilitating HIV testing and linkage to care - the UK experience
European Centre for Disease Prevention and Control
 
PDF
Scaling up HIV treatment - the Malta experience
European Centre for Disease Prevention and Control
 
PDF
Scaling up HIV testing: the role of self-testing
European Centre for Disease Prevention and Control
 
PDF
Experience with the implementation of PrEP in France
European Centre for Disease Prevention and Control
 
PDF
Scaling-up harm reduction services to prevention HIV among people who inject ...
European Centre for Disease Prevention and Control
 
PPTX
Fast-tracking the end of AIDS in Europe
European Centre for Disease Prevention and Control
 
HCV Treatment Access across Europe - Raquel Peck
ReShape
 
Hepatitis C Research Gaps - Graham Cooke
ReShape
 
Facilitating HIV testing and linkage to care - the UK experience
European Centre for Disease Prevention and Control
 
Scaling up HIV treatment - the Malta experience
European Centre for Disease Prevention and Control
 
Scaling up HIV testing: the role of self-testing
European Centre for Disease Prevention and Control
 
Experience with the implementation of PrEP in France
European Centre for Disease Prevention and Control
 
Scaling-up harm reduction services to prevention HIV among people who inject ...
European Centre for Disease Prevention and Control
 
Fast-tracking the end of AIDS in Europe
European Centre for Disease Prevention and Control
 

What's hot (20)

PDF
Importance of HIV testing and linkage to care
European Centre for Disease Prevention and Control
 
PPTX
Co-infection Linkages
ReShape
 
PPTX
Community-based HIV testing: the Athens Checkpoint initiative
European Centre for Disease Prevention and Control
 
PDF
HIV: Reaching the 90-90-90 targets in europe
European Centre for Disease Prevention and Control
 
PDF
Dr Steve Gray @ MRF's Meningitis and Septicaemia 2019
Meningitis Research Foundation
 
PPTX
10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)
UC San Diego AntiViral Research Center
 
PPTX
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
UC San Diego AntiViral Research Center
 
PPTX
01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond
UC San Diego AntiViral Research Center
 
PPTX
04.10.20 | Updates in HIV Prevention from CROI 2020
UC San Diego AntiViral Research Center
 
PDF
04.03.20 | COVID-19 and HIV: What We Know and Efforts to Answer What We Don’t...
UC San Diego AntiViral Research Center
 
PPTX
02.05.21 | COVID-19 and Pregnancy
UC San Diego AntiViral Research Center
 
PPTX
03.19.21 | Updates in HIV Prevention from Virtual CROI 2021
UC San Diego AntiViral Research Center
 
PDF
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
UC San Diego AntiViral Research Center
 
PPTX
Are EU/EEA countries ready to monitor progress on hepatitis C programmes?
European Centre for Disease Prevention and Control
 
PPTX
PrEP and ChemSex: Looking forward
ReShape
 
PPTX
06.11.21 | Practical Aspects of Dealing with Weight Gain in People with HIV
UC San Diego AntiViral Research Center
 
PPTX
09.11.20 | Review of New Antiretrovirals
UC San Diego AntiViral Research Center
 
PPTX
04.09.21 | Making Sense of the COVID-19 Data in Persons with HIV
UC San Diego AntiViral Research Center
 
PPTX
04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV
UC San Diego AntiViral Research Center
 
PDF
Shahin Lockman, Botswana: Arc of and Response to the HIV Epidemic
The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics
 
Importance of HIV testing and linkage to care
European Centre for Disease Prevention and Control
 
Co-infection Linkages
ReShape
 
Community-based HIV testing: the Athens Checkpoint initiative
European Centre for Disease Prevention and Control
 
HIV: Reaching the 90-90-90 targets in europe
European Centre for Disease Prevention and Control
 
Dr Steve Gray @ MRF's Meningitis and Septicaemia 2019
Meningitis Research Foundation
 
10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)
UC San Diego AntiViral Research Center
 
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
UC San Diego AntiViral Research Center
 
01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond
UC San Diego AntiViral Research Center
 
04.10.20 | Updates in HIV Prevention from CROI 2020
UC San Diego AntiViral Research Center
 
04.03.20 | COVID-19 and HIV: What We Know and Efforts to Answer What We Don’t...
UC San Diego AntiViral Research Center
 
02.05.21 | COVID-19 and Pregnancy
UC San Diego AntiViral Research Center
 
03.19.21 | Updates in HIV Prevention from Virtual CROI 2021
UC San Diego AntiViral Research Center
 
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
UC San Diego AntiViral Research Center
 
Are EU/EEA countries ready to monitor progress on hepatitis C programmes?
European Centre for Disease Prevention and Control
 
PrEP and ChemSex: Looking forward
ReShape
 
06.11.21 | Practical Aspects of Dealing with Weight Gain in People with HIV
UC San Diego AntiViral Research Center
 
09.11.20 | Review of New Antiretrovirals
UC San Diego AntiViral Research Center
 
04.09.21 | Making Sense of the COVID-19 Data in Persons with HIV
UC San Diego AntiViral Research Center
 
04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV
UC San Diego AntiViral Research Center
 
Shahin Lockman, Botswana: Arc of and Response to the HIV Epidemic
The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics
 
Ad

Viewers also liked (16)

PPTX
The ChemSex phenomenon
ReShape
 
PDF
ChemSex
ReShape
 
PPTX
ChemSex - Early Interventions Considerations
ReShape
 
PPTX
ChemSex across Germany - What's known and what's not
ReShape
 
PPTX
ChemSex and Injecting
ReShape
 
PPTX
Towards a ChemSex map: Overview of data and evidence
ReShape
 
PPTX
ChemSex in therapy
ReShape
 
PPTX
ChemSex and Wellbeing Programme
ReShape
 
PPT
ChemSex: a community policy response
ReShape
 
PPTX
Common outcomes measurement framework
ReShape
 
PPTX
The HIV Cascade - Dr Laura Waters
ReShape
 
PPTX
PrEP delivery and controls
ReShape
 
PPTX
Sexual health interventions: prescribing, screening, risk assessments
ReShape
 
PPTX
Club Drug Clinic, Project Neptune and the G Trial
ReShape
 
PDF
Outreach and community engagement. Supporting & resourcing the gay community ...
ReShape
 
PPTX
Consent & Responsibility: a UK Perspective
ReShape
 
The ChemSex phenomenon
ReShape
 
ChemSex
ReShape
 
ChemSex - Early Interventions Considerations
ReShape
 
ChemSex across Germany - What's known and what's not
ReShape
 
ChemSex and Injecting
ReShape
 
Towards a ChemSex map: Overview of data and evidence
ReShape
 
ChemSex in therapy
ReShape
 
ChemSex and Wellbeing Programme
ReShape
 
ChemSex: a community policy response
ReShape
 
Common outcomes measurement framework
ReShape
 
The HIV Cascade - Dr Laura Waters
ReShape
 
PrEP delivery and controls
ReShape
 
Sexual health interventions: prescribing, screening, risk assessments
ReShape
 
Club Drug Clinic, Project Neptune and the G Trial
ReShape
 
Outreach and community engagement. Supporting & resourcing the gay community ...
ReShape
 
Consent & Responsibility: a UK Perspective
ReShape
 
Ad

Similar to Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe Orkin (20)

PDF
World Hepatitis Day 2015: Hepatitis prevention
Sri Lanka College of Sexual Health and HIV Medicine
 
PPT
HIV in the Philippines (esp. cebu)
ariannejassy07
 
PDF
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
StopTb Italia
 
PDF
05.29.20 | Owen Clinic Case: A Man with Constipation and Weight Loss
UC San Diego AntiViral Research Center
 
PDF
The HCV Treatment Revolution: A View from the Community Health Center
UC San Diego AntiViral Research Center
 
PDF
San Diego Primary Care Providers' Attitudes to HIV and HIV Testing
UC San Diego AntiViral Research Center
 
PDF
4. Samir Dervisevic hepatitis b antenatal screening algorithms and reporting
PHEScreening
 
PPTX
Can we end the HIV/AIDS epidemic? Josip begovac
PinHealth
 
PPTX
Сравнение режимов лечения ВИЧ в разрезе различных клинических сценариев.ART...
hivlifeinfo
 
PPTX
HIV and Hepatitis C by Dr Alison Ratcliff
CICM 2019 Annual Scientific Meeting
 
PPT
Wesat2105
Mohamed Rafique
 
PPTX
HCV 2014: ICORN Prof Suzanne Norris
icornpresentations
 
PPTX
M01 Introduction to EID and POC EID Testing.pptx
DagneBodena1
 
PPT
Hepatitis C Infection – Screening, Treatment and (as) Prevention in the Comm...
icornpresentations
 
PPT
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
HopkinsCFAR
 
PPTX
Hepatitis-C-Overview_Final.pptx regarding hepatitc causes treatment
RinyKhurshid1
 
PPTX
HEPATITIS part 2.pptx
JazeelaMohamedSiddiq
 
PPTX
Dr Anna Garner_0.pptx
TreskaQadir
 
PDF
Clinical aspects of hepatitis e virus infection
Cornelia Adlhoch
 
World Hepatitis Day 2015: Hepatitis prevention
Sri Lanka College of Sexual Health and HIV Medicine
 
HIV in the Philippines (esp. cebu)
ariannejassy07
 
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
StopTb Italia
 
05.29.20 | Owen Clinic Case: A Man with Constipation and Weight Loss
UC San Diego AntiViral Research Center
 
The HCV Treatment Revolution: A View from the Community Health Center
UC San Diego AntiViral Research Center
 
San Diego Primary Care Providers' Attitudes to HIV and HIV Testing
UC San Diego AntiViral Research Center
 
4. Samir Dervisevic hepatitis b antenatal screening algorithms and reporting
PHEScreening
 
Can we end the HIV/AIDS epidemic? Josip begovac
PinHealth
 
Сравнение режимов лечения ВИЧ в разрезе различных клинических сценариев.ART...
hivlifeinfo
 
HIV and Hepatitis C by Dr Alison Ratcliff
CICM 2019 Annual Scientific Meeting
 
Wesat2105
Mohamed Rafique
 
HCV 2014: ICORN Prof Suzanne Norris
icornpresentations
 
M01 Introduction to EID and POC EID Testing.pptx
DagneBodena1
 
Hepatitis C Infection – Screening, Treatment and (as) Prevention in the Comm...
icornpresentations
 
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
HopkinsCFAR
 
Hepatitis-C-Overview_Final.pptx regarding hepatitc causes treatment
RinyKhurshid1
 
HEPATITIS part 2.pptx
JazeelaMohamedSiddiq
 
Dr Anna Garner_0.pptx
TreskaQadir
 
Clinical aspects of hepatitis e virus infection
Cornelia Adlhoch
 

More from ReShape (12)

PDF
European ChemSex forum report 2018
ReShape
 
PDF
Where's the hope? Dialogues for Solidarity - Session 4
ReShape
 
PDF
Where's the hope? Dialogues for solidarity, Session 3
ReShape
 
PDF
Where's the Hope? Dialogues for Solidarity, Session 2
ReShape
 
PDF
Where's the hope? Dialogues for Solidarity - Session 1
ReShape
 
PPTX
New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...
ReShape
 
PPTX
Hepatitis C Generic Drugs - Stuart Flanagan
ReShape
 
PDF
European ChemSex Forum Report
ReShape
 
PDF
G monitor sheet
ReShape
 
PPTX
Siegfried Schwarze
ReShape
 
PDF
Psychosexual issues and ChemSex
ReShape
 
PDF
CHECKOUT - Anonymous partner notification
ReShape
 
European ChemSex forum report 2018
ReShape
 
Where's the hope? Dialogues for Solidarity - Session 4
ReShape
 
Where's the hope? Dialogues for solidarity, Session 3
ReShape
 
Where's the Hope? Dialogues for Solidarity, Session 2
ReShape
 
Where's the hope? Dialogues for Solidarity - Session 1
ReShape
 
New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...
ReShape
 
Hepatitis C Generic Drugs - Stuart Flanagan
ReShape
 
European ChemSex Forum Report
ReShape
 
G monitor sheet
ReShape
 
Siegfried Schwarze
ReShape
 
Psychosexual issues and ChemSex
ReShape
 
CHECKOUT - Anonymous partner notification
ReShape
 

Recently uploaded (20)

PDF
Opening discussion for urban disease control and its challenges
Phathai Singkham
 
DOCX
RUHS II MBBS Pathology Paper-I with Answer Key | 30 July 2025 (New Scheme)
Shivankan Kakkar
 
PPTX
Acute abdomen in Gyne Obs obstetrics.pptxandGynaecology.pptx
abdiwmh75
 
DOCX
Paediatrics Question Papers – III MBBS (Part II), RUHS Main Exam 2025-2016
Shivankan Kakkar
 
PPTX
Fever and pyrexia of unknown origin.pptx
dineshsateesh001
 
PPTX
Anaesthesia Machine - Safety Features and Recent Advances - Dr.Vaidyanathan R
VAIDYANATHAN R
 
PDF
Solution of Psycho ED: Best Sexologist in Patna, Bihar India Dr. Sunil Dubey
Sexologist Dr. Sunil Dubey - Dubey Clinic
 
PPTX
Gastroschisis- Clinical Overview 18112311
Nathan Lupiya
 
PDF
NEET PG-2023 Expected questions and topics
Abhishek107368
 
PPT
Off-the-Shelf and on the Mark in NHL: Strategic Approaches With Bispecific An...
PVI, PeerView Institute for Medical Education
 
DOCX
NEET PG 2025 | Pharmacology Recall: 20 High-Yield Questions Simplified
Shivankan Kakkar
 
PDF
Rheumatoid arthritis RA_and_the_liver Prof AbdelAzeim Elhefny Ain Shams Univ...
Internal medicine department, faculty of Medicine Beni-Suef University Egypt
 
PDF
Bassem Matta, CCMA
Smiling Lungs
 
PPTX
Drug hypersensitivity Prof Ghada Shousha, Assistant Professor of pediatrics, ...
Internal medicine department, faculty of Medicine Beni-Suef University Egypt
 
PPTX
Ultrasound Machine - knobology-Dr. Vaidyanathan R.pptx
Dr.Vaidyanathan R
 
PPTX
4. Basic Principles managment of dislocation.pptx
orthojju
 
PPTX
Anatomy of eyelids basic anatomy covered along with abnormalities of eyelids
SummyBhatnagar1
 
PDF
Histology of Nose & paranasal sinuses - Dr Muhammad Ali Rabbani
MedicoseAcademics
 
PPTX
Pharmacology is the scientific study of how drugs and other chemical substanc...
tarun35435605
 
PPTX
CEPHALOPELVIC DISPROPORTION (Mufeez).pptx
mufeezwanim2
 
Opening discussion for urban disease control and its challenges
Phathai Singkham
 
RUHS II MBBS Pathology Paper-I with Answer Key | 30 July 2025 (New Scheme)
Shivankan Kakkar
 
Acute abdomen in Gyne Obs obstetrics.pptxandGynaecology.pptx
abdiwmh75
 
Paediatrics Question Papers – III MBBS (Part II), RUHS Main Exam 2025-2016
Shivankan Kakkar
 
Fever and pyrexia of unknown origin.pptx
dineshsateesh001
 
Anaesthesia Machine - Safety Features and Recent Advances - Dr.Vaidyanathan R
VAIDYANATHAN R
 
Solution of Psycho ED: Best Sexologist in Patna, Bihar India Dr. Sunil Dubey
Sexologist Dr. Sunil Dubey - Dubey Clinic
 
Gastroschisis- Clinical Overview 18112311
Nathan Lupiya
 
NEET PG-2023 Expected questions and topics
Abhishek107368
 
Off-the-Shelf and on the Mark in NHL: Strategic Approaches With Bispecific An...
PVI, PeerView Institute for Medical Education
 
NEET PG 2025 | Pharmacology Recall: 20 High-Yield Questions Simplified
Shivankan Kakkar
 
Rheumatoid arthritis RA_and_the_liver Prof AbdelAzeim Elhefny Ain Shams Univ...
Internal medicine department, faculty of Medicine Beni-Suef University Egypt
 
Bassem Matta, CCMA
Smiling Lungs
 
Drug hypersensitivity Prof Ghada Shousha, Assistant Professor of pediatrics, ...
Internal medicine department, faculty of Medicine Beni-Suef University Egypt
 
Ultrasound Machine - knobology-Dr. Vaidyanathan R.pptx
Dr.Vaidyanathan R
 
4. Basic Principles managment of dislocation.pptx
orthojju
 
Anatomy of eyelids basic anatomy covered along with abnormalities of eyelids
SummyBhatnagar1
 
Histology of Nose & paranasal sinuses - Dr Muhammad Ali Rabbani
MedicoseAcademics
 
Pharmacology is the scientific study of how drugs and other chemical substanc...
tarun35435605
 
CEPHALOPELVIC DISPROPORTION (Mufeez).pptx
mufeezwanim2
 

Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe Orkin

  • 1. Testing Strategies for HIV and HCV: similarities and differences Dr Chloe Orkin Consultant Physician & Honorary Reader in HIV Medicine Barts Health NHS Trust
  • 2. Deaths attributable to HIV and Hepatitis in Western Europe Global Burden of Disease Study: Cowie et al J Hep 2014 ;60 (Suppl 1):O86 -A relatively higher burden of HIV-related mortality until 1995 -HIV mortality declines from 2000 onwards -HCV deaths increasing
  • 3. HIV care cascade - WHO target WHO consolidated guidelines on HIV testing services. July 2015.
  • 4. HIV care cascade - UK Public Health England. HIV in the United Kingdom 2014 report. November 2014. 76%
  • 5. HCV care cascade in the UK 1. Public Health England. Hepatitis C in the UK 2015 report. July 2015. 2. Harris RJ et al. J Hepatol 2014;61:530–7. SVR ~50% 3% 63% 214,000 with HCV1 ~100,000 diagnosed 6000 per year2 ‘The great unknown’ svr
  • 6. HIV/HCV cascades: failing to diagnose 90% …. screening is the first step… TESTING SCREENING ASSESSMENT TREATMENT CURE
  • 7. HIV - where does testing happen in the UK ?
  • 8. UK HIV testing summary • HIV seroprevalence data underpins testing strategies • HIV testing occurring (hospital/community) • Tailor testing methods to the setting: oral swabs /rapid tests in outreach/STI vs. serology in ante-natal or the ED • De-exceptionalising HIV testing is important in non-traditional settings • Staff perceptions affect successful implementation • Sustainability is a key challenge in non-traditional settings such as the ED/MAU/ITU • HIV testing has moved beyond non-traditional settings into ‘DIY’ testing
  • 9. UK Guidelines HCV Testing = targeted testing At-risk populations: • PWID (about 90% being tested 1) • Prisons (8% of receptions tested within 30 days1) • Immigration centres • ‘Promote’ in GUM to those at high risk 1. Cosgrove P. Public health England Report: Hepatitis Epidemiology in the South East
  • 10. HCV Epidemic UK : gender
  • 11. UK Epidemic: Ethnicity Proportion testing positive for HCV-Ab by ethnicity in sentinel laboratories in the South East , 2010-2014
  • 12. Generalised epidemic= universal screening • Targeted testing not helpful • Universal approach
  • 13. US HCV: screening amongst ‘baby-boomers’ • Prevalence in this cohort > 3% • One time ‘birth cohort’ screening if born 1945–65 • Highly cost-effective Centers for Disease Control and Prevention. MMWR 2012;61:1–33. Centers for Disease Control and Prevention. MMWR 1998;47:1–39. Smith BD et al. AASLD 2011. Abstract 394.
  • 14. Differences in testing in the UK HCV HIV
  • 15. Are we missing HCV cases? Sero-prevalence surveys are helpful

Editor's Notes

  • #4: Notably, in 2014 around 90% of those diagnosed with HIV in the UK had initiated ART, with 93% of those on ART having a suppressed viral load . The number of people living with HIV in the UK continues to increase and by the end of 2013 was estimated to be 107,800 (95% credible interval 101,600-115,800) of whom 24% were undiagnosed.
  • #5: Notably, in 2014 around 90% of those diagnosed with HIV in the UK had initiated ART, with 93% of those on ART having a suppressed viral load . The number of people living with HIV in the UK continues to increase and by the end of 2013 was estimated to be 107,800 (95% credible interval 101,600-115,800) of whom 24% were undiagnosed.
  • #6: Notably, in 2014 around 90% of those diagnosed with HIV in the UK had initiated ART, with 93% of those on ART having a suppressed viral load . The number of people living with HIV in the UK continues to increase and by the end of 2013 was estimated to be 107,800 (95% credible interval 101,600-115,800) of whom 24% were undiagnosed. 215,000 + 100,000 tested Treated
  • #7: CCO – Thomas illustration
  • #10: MSM 75 non injecting 33 injecting 86 under influence of drugs High proportions of UPSI